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Letters to the Editor / Journal of Hepatology 51 (2009) 224–229 229Transient elastography vs. blood tests for the diagnosis of cirrhosis:
An empiric victoryTo the Editor:
Weunderstand the enthusiasm of Cale`s et al. [1] for the
test they have developed. However, we decided to com-
pare transient elastography (TE) with better validated
scores, i.e., APRI and Fibrotest [2,3], as well as cheaper
and routinely used laboratory tests (prothrombin index,
platelet count andAST/ALT ratio). Although the perfor-
mance of the Fibrometer appears to be very good in the
hands of its inventors, this score as been poorly evaluated
externally and is not yet widely used. As far as the diag-
nostic target is concerned, the cut-oﬀs used were those
recommended for cirrhosis by the manufacturer (Fibro-
test) or the authors (APRI andLok index).We alsowould
like to remind readers that the 90% of patients in whom
liver biopsy could have been avoided is the number of cor-
rectly classiﬁed patients (267 out of 298 [4]) using TE
(cut-oﬀ 12.5 kPa) in intention-to-diagnose analysis.
Cales’s discussion of our data is challenging, but their
statements are purely speculative and refer to a diﬀerent
patient population. Finally, we fully agree that combining
twounrelatedmethods such asTEand ablood test consis-
tently improves diagnostic accuracy, as we suggested for
the ﬁrst time in 2005 [5]. However, given the high perfor-
mance of TE for the diagnosis of cirrhosis, our strategy
seems more cost-eﬀective in clinical practice [6].
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